QUIDELORTHO CORP (QDEL)

US2197981051 - Common Stock

44.6  +0.02 (+0.04%)

After market: 44.6 0 (0%)

QUIDELORTHO CORP

NASDAQ:QDEL (12/26/2024, 8:00:01 PM)

After market: 44.6 0 (0%)

44.6

+0.02 (+0.04%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-5.56%
Sales Q2Q%-2.27%
CRS15.03
6 Month34.26%
Overview
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Ins Owners0.55%
Inst Owners85.58%
Market Cap3.00B
Shares67.26M
PE18.66
Fwd PE17.67
Dividend YieldN/A
Analysts74.29
Short Float %5.9%
Short Ratio4.33
IPO02-01 1991-02-01
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

QDEL Daily chart

Company Profile

QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 7,100 full-time employees. The firm sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The firm provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. The company provides support for its customers across more than 130 countries and territories.

Company Info

QUIDELORTHO CORP

9975 Summers Ridge Road

San Diego CALIFORNIA 92121

P: 18585521100

CEO: Douglas C. Bryant

Employees: 7100

Website: https://www.quidelortho.com/

QDEL Twits

Here you can normally see the latest stock twits on QDEL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example